https://www.selleckchem.com/products/AZD0530.html
Nonalcoholic fatty liver disease (NAFLD) is an inflammatory lipotoxic disorder with a prevalence of over 25% worldwide. However, safe and effective therapeutic agents for the management of NAFLD are still lacking. We aimed to investigate the hepatoprotective effect and molecular mechanism of 4-acetylantroquinonol B (4-AAQ, a natural ubiquinone derivative obtained from the mycelia of Antrodia cinnamomea. RAW264.7 and J774A.1 cells were treated with 4-AAQB and then stimulated with LPS or tunicamycin (TM) for 24h. Inflammatory responses,
Like
Comment
Share
